Sirolimus
- Product NDC
- 66689-347
- 11-digit product format
- 666890347
- Labeler code
- 66689
- Product ID
- 66689-347_909758a8-92f7-443a-bfe1-3f2f6cb98eb0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Sirolimus
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- VistaPharm, LLC
- Application
- ANDA211040
- Marketing category
- ANDA
- Marketing start
- 2019-01-28
- Substance
- SIROLIMUS
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Sirolimus
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| SIROLIMUS | 1 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | W36ZG6FT64 |
| Rxcui | 314230 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 66689-347-02 | Sirolimus | 1 in 1 CARTON | SOLUTION | 1 | | 11 |
| 66689-347-02 | Sirolimus | 1 in 1 KIT | SOLUTION | 1 | | 11 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 66689-347 | SIROLIMUS SOLUTION [VISTAPHARM, LLC] | 10 | Current NDC, Legacy NDC, 2 package rows | 20240209_19880f51-badb-4846-a02a-592a210690ab.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 66689-347-02 | 66689034702 | 1 CARTON in 1 KIT (66689-347-02) / 1 BOTTLE in 1 CARTON / 60 mL in 1 BOTTLE | 1 carton | 2019-01-28 | 0000-00-00 | No | No | Current |